My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioCardia, Inc. - Common Stock (NQ:BCDA)

1.410 +0.300 (+27.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioCardia, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
Crude Oil Rises 1%; Verb Technology Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling 100 points on Tuesday. The Dow traded down 0.31% to 34,728.66 while the NASDAQ rose 0.11% to 14,047.61. The S&P... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Nasdaq Turns Higher; US Factory Orders Fall 2.1% In July
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.15% to 34,785.92 while the NASDAQ rose 0.12% to 14,048.20. The S&P 500, also... 
Via Benzinga
Topics Stocks
Why Is BioCardia Stock Plunging Today?
BioCardia Inc (NASDAQ: BCDA) shares are down after the company released interim efficacy results in the phase 3 pivotal CardiAMP cell therapy  
Via Benzinga
Earnings Preview: BioCardia
 
Via Benzinga
Recap: BioCardia Q1 Earnings
 
Via Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
Via Benzinga
US Stocks Open Lower; Nasdaq Down 50 Points
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.18% to 34,776.28 while the NASDAQ fell... 
Via Benzinga
Topics Stocks
BioCardia Earnings Preview
 
Via Benzinga
BioCardia Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Earnings Outlook For BioCardia
 
Via Benzinga
BioCardia Outlines Detailed Cell Therapy Data From Heart Failure Study
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 56 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
BioCardia's Return On Capital Employed Insights
 
Via Benzinga
BioCardia's Heart Failure Cell Therapy Shows 100% Survival At Two Years
 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
BioCardia Pauses Enrollment In Late-Stage Study For Heart Failure Study on Monitoring Board Recommendation, Stock Plunges
BioCardia Inc (NASDAQ: BCDA) said the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase 3 pivotal CardiAMP Cell  
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones settled higher on Tuesday after recording losses for four straight sessions. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
From BioCardia, Inc.
Via Business Wire
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
Upgrades 
Via Benzinga
Earnings Preview For BioCardia
BioCardia (NASDAQ:BCDA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that BioCardia will... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.